Park Avenue Securities’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
Park Avenue Securities's ALAB Position: Q2 2026 in Review
Park Avenue Securities increased its Astera Labs (ALAB) stake by 3% in Q2 2026, buying an estimated $421K and bringing the position to 54,714 shares worth $26.4M. The position accounts for 0.17% of the portfolio, ranked #102.
Park Avenue Securities first reported a position in ALAB in Q4 2024 and has held it in 3 quarters since. 982 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.
- Park Avenue Securities held 54,714 shares of Astera Labs worth $26.4M as of Q2 2026.
- Park Avenue Securities bought 1,585 Astera Labs shares in Q2 2026, an estimated $421K.
- Astera Labs made up 0.17% of Park Avenue Securities's portfolio in Q2 2026, its #102 holding.
- Park Avenue Securities first reported a position in Astera Labs in Q4 2024 and has held it in 3 quarters since.
- 982 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.
Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.